Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation

EJNMMI Research

Volumn 1, Issue 1, 2011, Pages 1-7

  Autio, Anu ^a   Henttinen, Tiina ^a   Sipilä, Henri J ^a   Jalkanen, Sirpa ^b   Roivainen, Anne ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Gallium 68; Inflammation imaging; Mini PEG spacer; Positron emission tomography; Vascular adhesion protein 1

Indexed keywords

GALLIUM TETRAXETAN VASCULAR ADHESION PROTEIN 1 TARGETING PEPTIDE GA 68; GALLIUM TETRAXETAN VASCULAR ADHESION PROTEIN 1 TARGETING PEPTIDE POLYETHYLENE GLYCOL GA 68; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG STABILITY; DRUG UPTAKE; EX VIVO STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 84875912218     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-1-10     Document Type: Article

References (23)

1. Salmi M, Jalkanen S: A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992, 257:1407-1409.
2. Jaakkola K, Jalkanen S, Kaunismäki K, Vänttinen E, Saukko P, Alanen K, Kallajoki M, Voipio-Pulkki LM, Salmi M: Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol 2000, 36:122-129.
3. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S: Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 1998, 188:17-27.
4. Salmi M, Jalkanen S: VAP-1: an adhesin and an enzyme. Trends Immunol 2001, 22:211-216.
5. Tohka S, Laukkanen M-L, Jalkanen S, Salmi M: Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J 2001, 15:373-382.
6. Jalkanen S, Salmi M: VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol 2008, 28:18-26.
7. Yegutkin GG, Salminen T, Koskinen K, Kurtis C, McPherson MJ, Jalkanen S, Salmi M: A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress. Eur J Immunol 2004, 34:2276-2285.
8. Lankinen P, Mäkinen TJ, Pöyhönen TA, Virsu P, Salomäki S, Hakanen AJ, Jalkanen S, Aro HT, Roivainen A: (68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging 2008, 35:352-364.
9. Ujula T, Salomäki S, Virsu P, Lankinen P, Mäkinen TJ, Autio A, Yegutkin GG, Knuuti J, Jalkanen S, Roivainen A: Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing. osteomyelitis. Nucl Med Biol 2009, 36:631-641.
10. Autio A, Ujula T, Luoto P, Salomäki S, Jalkanen S, Roivainen A: PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide (68)Ga-DOTAVAP-P1: comparison with (18)F-FDG. Eur J Nucl Med Mol Imaging 2010, 37:1918-1925.
11. Harris JM, Chess RB: Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2002, 3:214-221.
12. Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams D: Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 2002, 169:983-992.
13. Ujula T, Salomäki S, Autio A, Luoto P, Tolvanen T, Lehikoinen P, Viljanen T, Sipilä H, Härkönen P, Roivainen A: 68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats-comparison with FDG. Mol Imaging Biol 2010, 12:259-268.
14. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS: Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J Nucl Med 2004, 45:1776-1783.
15. Wen X, Wu Q, Ke S, Ellis L, Charnsangavej C, Delpassand AS, Wallace S, Li C: Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225. J Nucl Med 2001, 42:1530-1537.
16. DeNardo SJ, Liu R, Albrecht H, Natarajan A, Sutcliffe JL, Anderson C, Peng L, Ferdani R, Cherry SR, Lam KS: 111In-LLP2A-DOTA polyethylene glycoltargeting a4b1 integrin: comparative pharmacokinetics for imaging and therapy of lymphoid malignancies. J Nucl Med 2009, 50:625-634.
17. Wu Z, Li ZB, Cai W, He L, Chin FT, Li F, Chen X: 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of αvβ3 integrin expression. Eur J Nucl Med Mol Imaging 2007, 34:1823-1831.
18. Liu Z, Niu G, Shi J, Liu S, Wang F, Liu S, Chen X: 68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging. Eur J Nucl Med Mol Imaging 2009, 36:947-957.
19. Liu Z, Liu S, Wang F, Liu S, Chen X: Noninvasive imaging of tumor integrin expression using 18F-labeled RGD dimer peptide with PEG4 linkers. Eur J Nucl Med Mol Imaging 2009, 36:1296-1307.
20. Ke S, Wen X, Wu QP, Wallace S, Charnsangavej C, Stachowiak AM, Stephens CL, Abbruzzese JL, Podoloff DA, Li C: Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. J Nucl Med 2004, 45:108-115.
21. Burtea C, Laurent S, Lancelot E, Ballet S, Murariu O, Rousseaux O, Port M, Vander Elst L, Corot C, Muller RN: Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. Mol Pharm 2009, 6:1903-1919.
22. Ke T, Jeong EK, Wang X, Feng Y, Parker DL, Lu ZR: RGD targeted poly(lglutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker αvβ3 integrin with MRTI mapping. Int J Nanomedicine 2007, 2:191-199.
23. Silvola J, Autio A, Luoto P, Jalkanen S, Roivainen A: Preliminary evaluation of novel 68Ga-DOTAVAP-PEG-P2 peptide targeting vascular adhesion protein-1. Clin Physiol Funct Imaging 2010, 30:75-78.